Literature DB >> 23436478

Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression.

Daniele Pierobon1, Maria Carla Bosco, Fabiola Blengio, Federica Raggi, Alessandra Eva, Miriam Filippi, Tiziana Musso, Francesco Novelli, Paola Cappello, Luigi Varesio, Mirella Giovarelli.   

Abstract

DCs are powerful antigen-presenting cells central in the orchestration of innate and acquired immunity. DC development, migration, and activities are intrinsically linked to the microenvironment. DCs migrate through pathologic tissues before reaching their final destination in the lymph nodes. Hypoxia, a condition of low partial oxygen pressure, is a common feature of many pathologic situations, capable of modifying DC phenotype and functional behavior. We studied human monocyte-derived immature DCs generated under chronic hypoxic conditions (H-iDCs). We demonstrate by gene expression profiling the upregulation of a cluster of genes coding for antigen-presentation, immunoregulatory, and pattern recognition receptors, suggesting a stimulatory role for hypoxia on iDC immunoregulatory functions. In particular, we show that H-iDCs express triggering receptor expressed on myeloid cells(TREM-1), a member of the Ig superfamily of immunoreceptors and an amplifier of inflammation. This effect is reversible because H-iDC reoxygenation results in TREM-1 down-modulation. TREM-1 engagement promotes upregulation of T-cell costimulatory molecules and homing chemokine receptors, typical of mature DCs, and increases the production of proinflammatory, Th1/Th17-priming cytokines/chemokines, resulting in increased T-cell responses. These results suggest that TREM-1 induction by the hypoxic microenvironment represents a mechanism of regulation of Th1-cell trafficking and activation by iDCs differentiated at pathologic sites.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436478     DOI: 10.1002/eji.201242709

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.

Authors:  Valerie Cuvier; Ulrike Lorch; Stephan Witte; Aurelie Olivier; Sebastien Gibot; Isabelle Delor; Jean-Jacques Garaud; Marc Derive; Margarita Salcedo-Magguilli
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

2.  Regulation of Langerhans cell functions in a hypoxic environment.

Authors:  Daniele Pierobon; Federica Raggi; Irene Cambieri; Simone Pelassa; Sergio Occhipinti; Paola Cappello; Francesco Novelli; Tiziana Musso; Alessandra Eva; Carlotta Castagnoli; Luigi Varesio; Mirella Giovarelli; Maria Carla Bosco
Journal:  J Mol Med (Berl)       Date:  2016-03-10       Impact factor: 4.599

Review 3.  The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases.

Authors:  Chunyan Zhang; Xugang Kan; Baole Zhang; Haibo Ni; Jianfeng Shao
Journal:  Mol Brain       Date:  2022-10-22       Impact factor: 4.399

4.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

Review 5.  Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

Authors:  Ursula Fearon; Mary Canavan; Monika Biniecka; Douglas J Veale
Journal:  Nat Rev Rheumatol       Date:  2016-05-26       Impact factor: 20.543

Review 6.  Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.

Authors:  Vinit Kumar; Dmitry I Gabrilovich
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

7.  Biophysical and epigenetic regulation of cancer stemness, invasiveness and immune action.

Authors:  Praveen Krishna Veerasubramanian; Annie Trinh; Navied Akhtar; Wendy F Liu; Timothy L Downing
Journal:  Curr Tissue Microenviron Rep       Date:  2020-11-02

Review 8.  The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis.

Authors:  Marco Genua; Sergio Rutella; Carmen Correale; Silvio Danese
Journal:  J Transl Med       Date:  2014-10-28       Impact factor: 5.531

Review 9.  Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?

Authors:  Kelsey Roe; Sébastien Gibot; Saguna Verma
Journal:  Front Microbiol       Date:  2014-11-26       Impact factor: 5.640

10.  Noninvasive Fluorine-19 Magnetic Resonance Relaxometry Measurement of the Partial Pressure of Oxygen in Acellular Perfluorochemical-loaded Alginate Microcapsules Implanted in the Peritoneal Cavity of Nonhuman Primates.

Authors:  Susan A Safley; Melanie L Graham; Bradley P Weegman; Samuel A Einstein; Graham F Barber; Jody J Janecek; Lucas A Mutch; Amar Singh; Sabarinathan Ramachandran; Michael Garwood; Athanassios Sambanis; Klearchos K Papas; Bernhard J Hering; Collin J Weber
Journal:  Transplantation       Date:  2020-02       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.